Skip to main content
logo
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
27.18
-1.45 (-5.06%)
Jul 31, 2026, 12:07 PM EDT - Market open

Alto Neuroscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,057568114---
Market Cap Growth
1162.96%397.79%----
Enterprise Value
872.31412.34-39.3000
Last Close Price
27.1817.804.23---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.123.760.75---
P/TBV Ratio
3.393.400.69---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
--0.58---
EV/EBIT Ratio
--0.57---
EV/FCF Ratio
--0.79---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.130.100.140.280
Net Debt / Equity Ratio
-1.00-1.03-1.011.011.012.06
Net Debt / EBITDA Ratio
3.172.372.251.941.352.12
Net Debt / FCF Ratio
3.893.013.102.141.842.59
Quick Ratio
20.1115.5816.8114.718.7515.03
Current Ratio
20.5215.6916.9215.228.8515.30
Return on Equity (ROE)
-37.67%-41.80%-55.53%-70.06%-93.12%-35.77%
Return on Assets (ROA)
-33.77%-36.64%-51.94%-55.00%-73.30%-42.60%
Return on Invested Capital (ROIC)
-925.12%-842.13%-1453.29%-2633.86%-2004.26%-959.03%
Return on Capital Employed (ROCE)
-35.66%-38.93%-55.21%-59.87%-80.78%-45.46%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-12.42%-17.28%-559.39%-8.27%-42.81%-
Total Shareholder Return
-12.42%-17.28%-559.39%-8.27%-42.81%-
SEC Filings: 10-K · 10-Q